| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42385-984-01 | 42385-984 | HUMAN PRESCRIPTION DRUG | Flucytosine | Flucytosine | CAPSULE | ORAL | 20250724 | N/A | ANDA | ANDA218005 | Laurus Labs Limited | FLUCYTOSINE | 500 mg/1 | 100 CAPSULE in 1 BOTTLE (42385-984-01) |
| 42385-984-27 | 42385-984 | HUMAN PRESCRIPTION DRUG | Flucytosine | Flucytosine | CAPSULE | ORAL | 20250724 | N/A | ANDA | ANDA218005 | Laurus Labs Limited | FLUCYTOSINE | 500 mg/1 | 10 BLISTER PACK in 1 CARTON (42385-984-27) / 10 CAPSULE in 1 BLISTER PACK |
| 42385-983-27 | 42385-983 | HUMAN PRESCRIPTION DRUG | Flucytosine | Flucytosine | CAPSULE | ORAL | 20250724 | N/A | ANDA | ANDA218005 | Laurus Labs Limited | FLUCYTOSINE | 250 mg/1 | 10 BLISTER PACK in 1 CARTON (42385-983-27) / 10 CAPSULE in 1 BLISTER PACK |
| 42385-983-01 | 42385-983 | HUMAN PRESCRIPTION DRUG | Flucytosine | Flucytosine | CAPSULE | ORAL | 20250724 | N/A | ANDA | ANDA218005 | Laurus Labs Limited | FLUCYTOSINE | 250 mg/1 | 100 CAPSULE in 1 BOTTLE (42385-983-01) |